Philip L. Herschman

TL;DR: Select demographic characteristics may be less important as predictors of outcome after patients have been in treatment beyond a minimum period of time, while others may become more important later on in treatment.

TL;DR: The more prudent question appears to be not whether treatment works, but rather what are the specific programmatic elements that comprise an adequate continuing care model that appear to be essential if a reasonable expectation of robust recovery is desired.

TL;DR: Comparable rates of illicit drug use at 6 months may be expected irrespective of maintenance medication, while increased retention may beexpected for patients maintained on methadone relative to those maintained on Suboxone or Subutex.

TL;DR: XR-NTX was associated with higher rates of residential and early post-residential care engagement in patients with opioids dependence and may be an effective adjunct in the residential treatment and aftercare of patients with opioid dependence.

TL;DR: Few of the demographic and clinical variables appear to provide a basis for a priori judgment about whether or not a patient presenting for MMT is likely to have a favorable long-term outcome, however, the findings do suffice to assist in making systematic improvements in MMT planning and in identifying particular subgroups of patients at risk for poor treatment response early on in the MMT process.